Article

Minimal residual disease: optimal methods, timing, and clinical relevance for an individual patient

2012-12-08

Abstract excerpt

Abstract After approximately 20 years of development and after several prospective clinical trials, the detection of minimal residual disease (MRD) has emerged as part of state-of-the-art diagnostics to guide the majority of contemporary treatment programs both in pediatric and adult acute lymphoblastic leukemia (ALL). For ALL, several methods of MRD analysis are available, but 2 are widely applicable. One is base...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: bed4cd17-528f-59c9-aed1-46d4795723bd
DOI: 10.1182/asheducation.v2012.1.137.3798216

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Minimal residual disease: optimal methods, timing, and clinical relevance for an individual patientDOI 10.1182/asheducation.v2012.1.137.3798216Read

Minimal residual disease diagnostics in acute lymphoblastic leukemia: need for sensitive, fast, and standardized technologiesSemantic proximity Read

Detection and management of minimal residual disease in acute lymphoblastic leukemiaSemantic proximity Read

Minimal Residual Disease Detection in Acute Lymphoblastic LeukemiaSemantic proximity Read

Minimal Residual Disease in Acute Lymphoblastic Leukemia: Technical and Clinical AdvancesSemantic proximity Read

An update on PCR use for minimal residual disease monitoring in acute lymphoblastic leukemiaSemantic proximity Read

Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets Report of the BIOMED-1 CONCERTED ACTION: Investigation of minimal residual disease in acute leukemiaSemantic proximity Read

Detection of minimal residual disease in pediatric acute lymphoblastic leukemiaSemantic proximity Read

Status of minimal residual disease testing in childhood haematological malignanciesSemantic proximity Read

Optimizing Molecular Minimal Residual Disease Analysis in Adult Acute Lymphoblastic LeukemiaSemantic proximity Read

Minimal Residual Disease Prior to and After Haematopoietic Stem Cell Transplantation in Children and Adolescents With Acute Lymphoblastic Leukaemia: What Level of Negativity Is Relevant?Semantic proximity Read

Optimization of PCR-based minimal residual disease diagnostics for childhood acute lymphoblastic leukemia in a multi-center settingSemantic proximity Read

Quantitative analysis of minimal residual disease predicts relapse in children with B-lineage acute lymphoblastic leukemia in DFCI ALL Consortium Protocol 95-01Semantic proximity Read